Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06802003

Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models

Early Prediction of Acute Exacerbations of COPD Using Wearable and Portable Remote Monitoring Technology With AI/ML Empowered Platforms: A Prospective Clinical Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

This study is aimed to collect real-time physiological data using two wearable devices (a biometric ring and a biometric wristband), daily lung mechanical measurements by a handheld oscillometer, and participant-reported symptoms in patients with COPD remotely from their home environment. The data will be used to train and validate artificial intelligence and machine learning (AI/ML) models to predict COPD exacerbations in advance of their actual occurrence. The data will also be used to test the new severity classification system for exacerbations of COPD, as well as to determine important relationships between physiological measurements from the wearable devices, the handheld oscillometer, the self-reported symptoms, and the tests performed at the baseline visit.

Detailed description

A single-site, prospective, observational cohort study to collect high-quality multidimensional data from the wearable/portable devices, as well as symptom and exacerbation data, in high-risk patients with frequent exacerbations in order to develop a COPD exacerbation predictive model.

Conditions

Interventions

TypeNameDescription
DEVICEBiometric wearable and handheld devicesIn this study, participants will be equipped with biometric wearable devices, i.e. ring and wristband, as well as with a handheld oscillometer, to measure their physiological parameters and lung mechanical changes (lung function).

Timeline

Start date
2025-05-22
Primary completion
2026-05-31
Completion
2026-08-31
First posted
2025-01-30
Last updated
2025-05-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06802003. Inclusion in this directory is not an endorsement.